This inventor holds 1 USPTO granted patent. Top assignee: University of Utah Research Foundation. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Annette Fernandez and Her Patent on an Antitumor Compound.
Introduction
Annette Fernandez is associated with Philadelphia, Pennsylvania, and the University of Utah Research Foundation. Her patent work concerns vitilevuamide, a compound investigated for antitumor activity.
Latest Patents
The supplied information lists one patent for Fernandez: “Cyclic Peptide Antitumor Agent from an Ascidian.” It discloses purified vitilevuamide, a bicyclic depsipeptide obtained from the ascidians *Didemnum cuculliferum* and *Polysyncraton lithostrotum*. The patent describes the compound’s antitumor activity in standard in vitro and in vivo assays, an anticancer composition combining vitilevuamide with an inert carrier, and a method of treating cancer by administering that composition. The supplied total is 1 patent.
Career Highlights
The patent highlights research into a naturally derived compound and its potential application in cancer treatment. The University of Utah Research Foundation is identified as Fernandez’s affiliated organization in the supplied information.
Collaborations
Chris M. Ireland is listed as Fernandez’s coworker. The patent’s subject matter reflects research involving the isolation and evaluation of vitilevuamide and its potential therapeutic use.
Conclusion
Annette Fernandez’s listed patent documents the investigation of vitilevuamide as an antitumor agent and describes its proposed use in an anticancer composition and treatment method.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile